RT Journal Article SR Electronic T1 Health Equity Considerations for Developing and Reporting Patient-reported Outcomes in Clinical Trials: A Report from the OMERACT Equity Special Interest Group JF The Journal of Rheumatology JO J Rheumatol FD The Journal of Rheumatology SP jrheum.160975 DO 10.3899/jrheum.160975 A1 Jennifer Petkovic A1 Jennifer L. Barton A1 Caroline Flurey A1 Niti Goel A1 Christie M. Bartels A1 Cheryl Barnabe A1 Maarten P.T. de Wit A1 Anne Lyddiatt A1 Diane Lacaille A1 Vivian Welch A1 Annelies Boonen A1 Beverley Shea A1 Robin Christensen A1 Lara J. Maxwell A1 Willemina Campbell A1 Janet Jull A1 Karine Toupin-April A1 Jasvinder A. Singh A1 Charles H. Goldsmith A1 Antoine G. Sreih A1 Christoph Pohl A1 Catherine Hofstetter A1 Dorcas E. Beaton A1 Rachelle Buchbinder A1 Francis Guillemin A1 Peter S. Tugwell YR 2017 UL http://www.jrheum.org/content/early/2017/02/09/jrheum.160975.abstract AB Objective Despite advances integrating patient-centered outcomes into rheumatologic studies, concerns remain regarding their representativeness across diverse patient groups and how this affects equity. The Outcome Measures in Rheumatology (OMERACT) Equity Working Group aims to determine whether and how to address equity issues within the core outcome sets of domains and instruments. Methods We surveyed current and previous OMERACT meeting attendees and members of the Campbell and Cochrane Equity Group regarding whether to address equity issues within the OMERACT Filter 2.0 Core Outcome Sets and how to assess the appropriateness of domains, instruments, and measurement properties among diverse patients. At OMERACT 2016, results of the survey and a narrative review of differential psychosocial effects of rheumatoid arthritis (i.e., on men) were presented to stimulate discussion and develop a research agenda. Results We proposed 6 moments for which an equity lens could be added to the development, selection, or testing of patient-reported outcome measures (PROM): (1) recruitment, (2) domain selection, (3) feasibility in diverse settings, (4) instrument validity, (5) thresholds of meaning, and (6) consideration of statistical power of subgroup analyses for outcome reporting. Conclusion There is a need to (1) conduct a systematic review to assess how equity and population characteristics have been considered in PROM development and whether these differences influence the ranking of importance of outcome domains or a patient’s response to questionnaire items, and (2) conduct the same survey described above with patients representing groups experiencing health inequities.